We are live on ! Find out more
Thrivent Financial for Lutherans

Thrivent Financial for Lutherans Portfolio holdings

AUM $52.5B
1-Year Est. Return 27.12%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+27.12%
3 Year Est. Return
+79.38%
5 Year Est. Return
+100.59%
10 Year Est. Return
+446.23%
AUM
$36.4B
AUM Growth
-$1.11B
Cap. Flow
+$336M
Cap. Flow %
0.92%
Top 10 Hldgs %
13.53%
Holding
2,531
New
125
Increased
1,361
Reduced
798
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 15.55%
2 Financials 12.77%
3 Healthcare 12.05%
4 Industrials 11.1%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLQT icon
2301
SelectQuote
SLQT
$121M
$93K ﹤0.01%
127,459
+4,705
+4% +$7.82K
TEVA icon
2302
Teva Pharmaceuticals
TEVA
$41.2B
$93K ﹤0.01%
11,498
+330
+3% +$2.92K
ZYME icon
2303
Zymeworks
ZYME
$1.67B
$93K ﹤0.01%
+16,082
New +$96.9K
DMF
2304
DELISTED
BNY Mellon Municipal Income
DMF
$92K ﹤0.01%
15,290
+2,556
+20% +$17.3K
PFN
2305
PIMCO Income Strategy Fund II
PFN
$703M
$91K ﹤0.01%
13,188
+159
+1% +$1.24K
LILA icon
2306
Liberty Latin America Class A
LILA
$1.67B
$89K ﹤0.01%
21,161
CYD icon
2307
China Yuchai International
CYD
$1.78B
$86K ﹤0.01%
11,737
WTTR icon
2308
Select Water Solutions
WTTR
$2.61B
$81K ﹤0.01%
11,639
AXLA
2309
DELISTED
Axcella Health Inc. Common Stock
AXLA
$67K ﹤0.01%
+1,380
New +$73.3K
EPIX
2310
DELISTED
ESSA Pharma
EPIX
$56K ﹤0.01%
+31,337
New +$82.6K
NCZ
2311
Virtus Convertible & Income Fund II
NCZ
$301M
$42K ﹤0.01%
3,710
+192
+5% +$2.53K
THCX
2312
DELISTED
AXS Cannabis ETF
THCX
$37K ﹤0.01%
+1,350
New +$49.5K
GRAB icon
2313
Grab
GRAB
$14.9B
$35K ﹤0.01%
13,444
+2,744
+26% +$8.31K
GSAT icon
2314
Globalstar
GSAT
$10.8B
$32K ﹤0.01%
1,344
HUT
2315
Hut 8
HUT
$10.9B
$23K ﹤0.01%
2,539
+301
+13% +$3.13K
LYG icon
2316
Lloyds Banking Group
LYG
$91.3B
$20K ﹤0.01%
11,233
-364
-3% -$756
KEEL
2317
Keel Infrastructure Corp
KEEL
$2.34B
$19K ﹤0.01%
17,663
+1,939
+12% +$2.65K
LCTX icon
2318
Lineage Cell Therapeutics
LCTX
$278M
$17K ﹤0.01%
+15,000
New +$22K
YARW
2319
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$12K ﹤0.01%
61
ZOM
2320
DELISTED
Zomedica Corp.
ZOM
$4K ﹤0.01%
20,925
ACCO icon
2321
Acco Brands
ACCO
$407M
-37,971
Closed -$248K
ACWX icon
2322
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
-21,927
Closed -$987K
AMRX icon
2323
Amneal Pharmaceuticals
AMRX
$5.79B
-51,282
Closed -$164K
AOM icon
2324
iShares Core Moderate Allocation ETF
AOM
$1.78B
-5,968
Closed -$233K
APEI icon
2325
American Public Education
APEI
$940M
-18,525
Closed -$299K

Similar funds

Thrivent Financial for Lutherans's Q3 2022 Portfolio in Review

As of Q3 2022, Thrivent Financial for Lutherans held 2,531 positions worth $36.4B, down 2.9% from $37.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Thrivent Financial for Lutherans's Q3 2022 filing shows 125 new, 1,361 increased, 798 reduced and 129 closed positions. Its largest new stake was Maravai LifeSciences: 2,559,746 shares worth $65.3M. The largest sale was Thermo Fisher Scientific, an estimated $126M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Thrivent Financial for Lutherans's largest Q3 2022 buy was Maravai LifeSciences: 2,559,746 shares worth $65.3M.
  • Thrivent Financial for Lutherans added most to Meta Platforms (Facebook) in Q3 2022, an estimated $219M increase.
  • Thrivent Financial for Lutherans's biggest Q3 2022 reduction was Thermo Fisher Scientific, cutting an estimated $126M.
  • Thrivent Financial for Lutherans fully exited Healthcare Realty Trust Incorporated in Q3 2022, selling an estimated $95.3M.
  • Thrivent Financial for Lutherans's ten largest holdings make up 14% of its $36.4B portfolio in Q3 2022.
  • Thrivent Financial for Lutherans opened 125 new positions and closed 129 in Q3 2022.
  • Thrivent Financial for Lutherans's portfolio value fell 2.9% quarter-over-quarter to $36.4B.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2022, filed 14 Nov 2022.